• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产儿贫血时血浆免疫反应性促红细胞生成素对“有效氧”的反应降低。

Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity.

作者信息

Brown M S, Garcia J F, Phibbs R H, Dallman P R

出版信息

J Pediatr. 1984 Nov;105(5):793-8. doi: 10.1016/s0022-3476(84)80309-1.

DOI:10.1016/s0022-3476(84)80309-1
PMID:6502313
Abstract

Erythropoietin, hemoglobin, hematocrit, oxygen affinity (P50), and reticulocyte counts were measured weekly starting at 1 week of age in 10 very-low-birth-weight infants and on a single occasion in 15 healthy men. In the adults, "available oxygen" (derived from oxygen carrying capacity and P50) averaged 13.1 ml/dl blood and the mean erythropoietin level was 15.2 mU/ml. Erythropoietin levels in the infants were inversely related to concentration of hemoglobin, P50, and available oxygen. However, despite the much lower mean "available oxygen" of 9.3 ml/dl in the infants compared with that in adults (P less than 0.001), the mean erythropoietin value of 8.2 mU/ml in the infants was less than in adults (P less than 0.001). Furthermore, the erythropoietin response to decreased "available oxygen" was lowest in the least mature infants. VLBW infants often develop clinical evidence of hypoxia during the anemia of prematurity. The relatively low erythropoietin levels in relation to "available oxygen" are compatible with a decreased erythropoietin response to hypoxia compared with that in adults. Such a difference in response could be a contributing factor to the anemia of prematurity.

摘要

对10名极低出生体重儿从1周龄开始每周测量促红细胞生成素、血红蛋白、血细胞比容、氧亲和力(P50)和网织红细胞计数,对15名健康男性仅进行一次测量。在成年人中,“有效氧”(由携氧能力和P50得出)平均为每毫升血液13.1毫升,促红细胞生成素平均水平为15.2毫单位/毫升。婴儿的促红细胞生成素水平与血红蛋白浓度、P50和有效氧呈负相关。然而,尽管婴儿的平均“有效氧”为9.3毫升/分升,远低于成年人(P<0.001),但婴儿的促红细胞生成素平均值为8.2毫单位/毫升,低于成年人(P<0.001)。此外,最不成熟的婴儿对“有效氧”降低的促红细胞生成素反应最低。极低出生体重儿在早产儿贫血期间常出现缺氧的临床证据。与成年人相比,与“有效氧”相关的促红细胞生成素水平相对较低,这与促红细胞生成素对缺氧的反应降低是一致的。这种反应差异可能是早产儿贫血的一个促成因素。

相似文献

1
Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity.早产儿贫血时血浆免疫反应性促红细胞生成素对“有效氧”的反应降低。
J Pediatr. 1984 Nov;105(5):793-8. doi: 10.1016/s0022-3476(84)80309-1.
2
Anemia of prematurity: determinants of the erythropoietin response.早产儿贫血:促红细胞生成素反应的决定因素
J Pediatr. 1984 Nov;105(5):786-92. doi: 10.1016/s0022-3476(84)80308-x.
3
Recombinant human erythropoietin in the treatment of anemia of prematurity.重组人促红细胞生成素治疗早产儿贫血
Am J Perinatol. 1995 Sep;12(5):314-8. doi: 10.1055/s-2007-994483.
4
Circulating erythroid progenitors in the anemia of prematurity.
N Engl J Med. 1987 Sep 17;317(12):728-33. doi: 10.1056/NEJM198709173171203.
5
Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
J Pediatr. 1991 Nov;119(5):781-8. doi: 10.1016/s0022-3476(05)80303-8.
6
Postnatal changes in erythropoietin levels in untransfused premature infants.未输血早产儿促红细胞生成素水平的产后变化。
J Pediatr. 1983 Oct;103(4):612-7. doi: 10.1016/s0022-3476(83)80600-3.
7
Plasma erythropoietin concentrations during the early anemia of prematurity.
Acta Paediatr Scand. 1983 Nov;72(6):827-31. doi: 10.1111/j.1651-2227.1983.tb09824.x.
8
The anemia of prematurity. Factors governing the erythropoietin response.
N Engl J Med. 1977 Mar 24;296(12):647-50. doi: 10.1056/NEJM197703242961202.
9
Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.重组人促红细胞生成素可刺激极低出生体重早产儿的红细胞生成并减少红细胞输注。
Pediatrics. 1995 Jan;95(1):1-8.
10
Anemia of prematurity. Current concepts in the issue of when to transfuse.早产儿贫血。关于何时输血问题的当前概念。
Pediatr Clin North Am. 1986 Feb;33(1):111-28. doi: 10.1016/s0031-3955(16)34972-0.

引用本文的文献

1
Anaemia of prematurity: pathophysiology and treatment.早产儿贫血:病理生理学与治疗。
Blood Rev. 2010 Nov;24(6):221-5. doi: 10.1016/j.blre.2010.08.001.
2
Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.促红细胞生成素的药代动力学/药效学分析表明,治疗新生儿贫血时需要更高剂量。
Pediatr Int. 2009 Feb;51(1):25-32. doi: 10.1111/j.1442-200X.2008.02648.x.
3
Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.早产儿贫血:促红细胞生成素与红细胞输血——并非如此简单。
Clin Perinatol. 2009 Mar;36(1):111-23. doi: 10.1016/j.clp.2008.09.009.
4
How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity.我如何为患有早产贫血和血小板减少症的婴儿输注红细胞和血小板。
Transfusion. 2008 Feb;48(2):209-17. doi: 10.1111/j.1537-2995.2007.01592.x. Epub 2008 Jan 7.
5
Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.维生素E补充剂在促红细胞生成素治疗早产儿贫血过程中的作用。
Arch Dis Child Fetal Neonatal Ed. 2003 Jul;88(4):F324-8. doi: 10.1136/fn.88.4.f324.
6
Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.重组人促红细胞生成素在预防和治疗早产儿贫血中的应用
Paediatr Drugs. 2002;4(2):111-21. doi: 10.2165/00128072-200204020-00004.
7
Plasma erythropoietin in newborn lambs.新生羔羊的血浆促红细胞生成素
Acta Vet Scand. 2000;41(4):381-5. doi: 10.1186/BF03549628.
8
Double blind trial of recombinant human erythropoietin in preterm infants.重组人促红细胞生成素用于早产儿的双盲试验。
Arch Dis Child. 1993 Mar;68(3 Spec No):291-6. doi: 10.1136/adc.68.3_spec_no.291.
9
IL-1 beta and IL-3-like activity in preterm infants.早产儿中的白细胞介素-1β和白细胞介素-3样活性
Clin Exp Immunol. 1993 Feb;91(2):320-4. doi: 10.1111/j.1365-2249.1993.tb05902.x.
10
Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.促红细胞生成素、蛋白质及铁剂补充与早产儿贫血的预防
Arch Dis Child. 1993 Jul;69(1 Spec No):19-23. doi: 10.1136/adc.69.1_spec_no.19.